Owing to its indirect action it is prone to tachyphylaxis as noradrenaline stores in sympathetic nerves are depleted
It is unlikely to be efficacious in the management of hypotension caused by drugs that affect neuronal storage, uptake, metabolism or release of neurotransmitters, e.g.:
Reserpine - depletes noradrenaline in neuronal granules
Alpha-methyl dopa - acts as a false transmitter
Also less efficacious where there is block of adrenoreceptors e.g. due to alpha blockade (e.g. phenoxybenzamine) or beta blockade (e.g. propranolol)
Absorption
Well absorbed from PO, IM or SC routes
Metabolism
It is not metabolised by COMT or MAO and therefore has a longer duration (elimination half-life 4hrs)
Some metabolism to phenylpropanolamine which is a central stimulant
Excretion
65% is excreted unchanged (with some metabolism in the liver)
Excretion enhanced under acidic conditions
Respiratory
Respiratory stimulant and bronchodilator
Cardiovascular
Increases HR and cardiac output
Increases BP
Increases coronary blood flow and myocardial oxygen consumption
May precipitate arrhythmias
Neurological
Rapidly crosses BBB
Increases MAC
Increases BIS value
Gastrointestinal
Splanchnic and renal blood flow is decreased and GFR falls
Can relax GI smooth muscle
Uteroplacental
Does not affect placental blood flow
Readily crosses the placental membrane; associated with poorer cord gas pH than phenylephrine
Interactions
Should be used with caution in those taking MAO-I's